| 000 | 01260 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250517065047.0 | ||
| 264 | 0 | _c20160520 | |
| 008 | 201605s 0 0 eng d | ||
| 022 | _a1474-5488 | ||
| 024 | 7 |
_a10.1016/S1470-2045(15)00547-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWatson, Ian | |
| 245 | 0 | 0 |
_aNICE guidance on pembrolizumab for advanced melanoma. _h[electronic resource] |
| 260 |
_bThe Lancet. Oncology _cJan 2016 |
||
| 300 |
_a21-2 p. _bdigital |
||
| 500 | _aPublication Type: News | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xtherapeutic use |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMelanoma _xdrug therapy |
| 650 | 0 | 4 | _aPractice Guidelines as Topic |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 | _aUnited Kingdom |
| 700 | 1 | _aDominguez, Pilar Pinilla | |
| 700 | 1 | _aDonegan, Eleanor | |
| 700 | 1 | _aCharles, Zoe | |
| 700 | 1 | _aRobertson, Janet | |
| 700 | 1 | _aAdam, E Jane | |
| 773 | 0 |
_tThe Lancet. Oncology _gvol. 17 _gno. 1 _gp. 21-2 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S1470-2045(15)00547-1 _zAvailable from publisher's website |
| 999 |
_c25499472 _d25499472 |
||